237 related articles for article (PubMed ID: 29123088)
21. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy.
Shan L; Cui S; Du C; Wan S; Qian Z; Achilefu S; Gu Y
Biomaterials; 2012 Jan; 33(1):146-62. PubMed ID: 21959006
[TBL] [Abstract][Full Text] [Related]
22. Nanog-mediated stem cell properties are critical for MBNL3-associated paclitaxel resistance of ovarian cancer.
Sun X; Diao X; Zhu X; Yin X; Cheng G
J Biochem; 2021 Sep; 169(6):747-756. PubMed ID: 33599261
[TBL] [Abstract][Full Text] [Related]
23. SYL3C aptamer-anchored microemulsion co-loading β-elemene and PTX enhances the treatment of colorectal cancer.
Zhou X; Cao C; Li N; Yuan S
Drug Deliv; 2019 Dec; 26(1):886-897. PubMed ID: 31524012
[TBL] [Abstract][Full Text] [Related]
24. Conjugation of paclitaxel to iron oxide nanoparticles for tumor imaging and therapy.
Liu D; Wu W; Chen X; Wen S; Zhang X; Ding Q; Teng G; Gu N
Nanoscale; 2012 Apr; 4(7):2306-10. PubMed ID: 22362270
[TBL] [Abstract][Full Text] [Related]
25. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
[TBL] [Abstract][Full Text] [Related]
26. Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model.
Wu D; Zheng Y; Hu X; Fan Z; Jing X
Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():68-75. PubMed ID: 26042692
[TBL] [Abstract][Full Text] [Related]
27. Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug.
Brunetti J; Pillozzi S; Falciani C; Depau L; Tenori E; Scali S; Lozzi L; Pini A; Arcangeli A; Menichetti S; Bracci L
Sci Rep; 2015 Dec; 5():17736. PubMed ID: 26626158
[TBL] [Abstract][Full Text] [Related]
28. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
[TBL] [Abstract][Full Text] [Related]
29. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
[TBL] [Abstract][Full Text] [Related]
30. Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
Chen Y; Feng S; Liu W; Yuan Z; Yin P; Gao F
Mol Pharm; 2017 Apr; 14(4):1190-1203. PubMed ID: 28212490
[TBL] [Abstract][Full Text] [Related]
31. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.
Wu J; Song C; Jiang C; Shen X; Qiao Q; Hu Y
Mol Pharm; 2013 Oct; 10(10):3555-63. PubMed ID: 23679916
[TBL] [Abstract][Full Text] [Related]
32. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of multi-functional tLyP-1-hyaluronic acid-paclitaxel conjugate endowed with broad anticancer scope.
Wang W; Li M; Zhang Z; Cui C; Zhou J; Yin L; Lv H
Carbohydr Polym; 2017 Jan; 156():97-107. PubMed ID: 27842858
[TBL] [Abstract][Full Text] [Related]
34. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
[TBL] [Abstract][Full Text] [Related]
35. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts.
Ye L; He J; Hu Z; Dong Q; Wang H; Fu F; Tian J
Food Chem Toxicol; 2013 Feb; 52():200-6. PubMed ID: 23149094
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
38. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
40. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells.
Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H
J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]